Close
  Indian J Med Microbiol
 

Figure 2: New views on the pathophysiology of acne vulgaris, modified from O'Neill and Gallo.[51] NF-kB: Nuclear factor kappa-light-chain-enhancer of activated B cells, TLR2: Toll-like receptor 2, LTA: Lipoteichoic acid, CAMP: Christie-Atkins-Munch-Peterson, FFAs: Free fatty acids, SCFAs: Short-chain fatty acids, ROS: Reactive oxygen species, MAPK: Mitogen-activated protein kinases, TRAF6: Tumor necrosis factor receptor-associated factor 6, TNF-α: Tumor necrosis factor α, MyD88: Myeloid differentiation primary response 88, IL-1α: Interleukin 1α, IL-1β: Interleukin 1β, IL-6: Interleukin 6.

Figure 2: New views on the pathophysiology of acne vulgaris, modified from O'Neill and Gallo.<sup>[51]</sup> NF-kB: Nuclear factor kappa-light-chain-enhancer of activated B cells, TLR2: Toll-like receptor 2, LTA: Lipoteichoic acid, CAMP: Christie-Atkins-Munch-Peterson, FFAs: Free fatty acids, SCFAs: Short-chain fatty acids, ROS: Reactive oxygen species, MAPK: Mitogen-activated protein kinases, TRAF6: Tumor necrosis factor receptor-associated factor 6, TNF-α: Tumor necrosis factor α, MyD88: Myeloid differentiation primary response 88, IL-1α: Interleukin 1α, IL-1β: Interleukin 1β, IL-6: Interleukin 6.